Becton, Dickinson and Company (BDX) Set to Announce Quarterly Earnings on Thursday

Becton, Dickinson and Company (NYSE:BDXGet Free Report) is set to issue its quarterly earnings data before the market opens on Thursday, February 1st. Analysts expect the company to announce earnings of $2.39 per share for the quarter. Becton, Dickinson and Company has set its FY24 guidance at $12.70 to $13.00 EPS.Parties interested in registering for the company’s conference call can do so using this link.

Becton, Dickinson and Company (NYSE:BDXGet Free Report) last posted its quarterly earnings data on Thursday, November 9th. The medical instruments supplier reported $3.42 earnings per share for the quarter, hitting the consensus estimate of $3.42. The company had revenue of $5.09 billion during the quarter, compared to analysts’ expectations of $5.02 billion. Becton, Dickinson and Company had a net margin of 7.66% and a return on equity of 13.91%. Becton, Dickinson and Company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company posted $2.75 earnings per share. On average, analysts expect Becton, Dickinson and Company to post $13 EPS for the current fiscal year and $14 EPS for the next fiscal year.

Becton, Dickinson and Company Stock Down 1.6 %

Shares of NYSE BDX opened at $234.57 on Thursday. The firm has a market cap of $68.12 billion, a PE ratio of 47.29, a P/E/G ratio of 1.90 and a beta of 0.46. Becton, Dickinson and Company has a 12-month low of $228.62 and a 12-month high of $287.32. The company’s fifty day simple moving average is $238.17 and its 200 day simple moving average is $255.68. The company has a quick ratio of 0.81, a current ratio of 1.31 and a debt-to-equity ratio of 0.57.

Becton, Dickinson and Company Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 29th. Stockholders of record on Friday, March 8th will be issued a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a dividend yield of 1.62%. Becton, Dickinson and Company’s dividend payout ratio is currently 76.61%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on BDX shares. Piper Sandler reduced their price objective on shares of Becton, Dickinson and Company from $305.00 to $280.00 and set an “overweight” rating for the company in a report on Friday, November 10th. Citigroup reduced their price objective on shares of Becton, Dickinson and Company from $282.00 to $260.00 in a report on Monday, October 2nd. StockNews.com started coverage on shares of Becton, Dickinson and Company in a report on Thursday, October 5th. They set a “hold” rating for the company. Raymond James lifted their price objective on shares of Becton, Dickinson and Company from $269.00 to $275.00 and gave the company an “outperform” rating in a report on Wednesday, January 3rd. Finally, TheStreet cut shares of Becton, Dickinson and Company from a “b” rating to a “c+” rating in a report on Thursday, November 9th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $278.83.

Read Our Latest Stock Analysis on Becton, Dickinson and Company

Insiders Place Their Bets

In other Becton, Dickinson and Company news, EVP Richard Byrd sold 2,156 shares of Becton, Dickinson and Company stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $238.47, for a total value of $514,141.32. Following the sale, the executive vice president now owns 4,120 shares of the company’s stock, valued at $982,496.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.31% of the company’s stock.

Institutional Trading of Becton, Dickinson and Company

Several hedge funds and other institutional investors have recently modified their holdings of BDX. Fairfield Bush & CO. bought a new stake in Becton, Dickinson and Company during the 1st quarter worth approximately $114,000. Sequoia Financial Advisors LLC increased its holdings in Becton, Dickinson and Company by 11.3% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,923 shares of the medical instruments supplier’s stock worth $778,000 after acquiring an additional 297 shares during the period. Brighton Jones LLC increased its holdings in Becton, Dickinson and Company by 8.8% during the 1st quarter. Brighton Jones LLC now owns 1,383 shares of the medical instruments supplier’s stock worth $368,000 after acquiring an additional 112 shares during the period. Zions Bancorporation N.A. increased its holdings in Becton, Dickinson and Company by 13.0% during the 1st quarter. Zions Bancorporation N.A. now owns 504 shares of the medical instruments supplier’s stock worth $134,000 after acquiring an additional 58 shares during the period. Finally, Mather Group LLC. increased its holdings in Becton, Dickinson and Company by 26.0% during the 1st quarter. Mather Group LLC. now owns 1,346 shares of the medical instruments supplier’s stock worth $358,000 after acquiring an additional 278 shares during the period. Institutional investors own 86.72% of the company’s stock.

About Becton, Dickinson and Company

(Get Free Report)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

See Also

Earnings History for Becton, Dickinson and Company (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.